Yorke Justin W. - 24 Jul 2025 Form 4/A - Amendment Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Director
Signature
/s/ Justin W. Yorke by John J. Wolfel, as Attorney-in-Fact
Issuer symbol
PCSA
Transactions as of
24 Jul 2025
Net transactions value
$0
Form type
4/A - Amendment
Filing time
18 Sep 2025, 16:26:07 UTC
Date Of Original Report
28 Jul 2025
Previous filing
31 Jan 2025
Next filing
15 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Yorke Justin W Director C/O PROCESSA PHARMACEUTICALS, INC., 601 21ST STREET SUITE 300, VERO BEACH /s/ Justin W. Yorke by John J. Wolfel, as Attorney-in-Fact 18 Sep 2025 0001361896

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PCSA Common Stock 3,737 24 Jul 2025 Direct
holding PCSA Common Stock 12,400 24 Jul 2025 By Directed Trust Company FBO Justin Yorke IRA
holding PCSA Common Stock 31,232 24 Jul 2025 By Richland Fund, LLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding PCSA Warrants 12,400 24 Jul 2025 Common Stock 12,400 $0.6500 By Directed Trust Company FBO Justin Yorke IRA
holding PCSA Warrants 6,200 24 Jul 2025 Common Stock 6,200 $0.6500 By Directed Trust Company FBO Justin Yorke IRA
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Amendment filed to retract the prior Form 4, which was filed in error.